ISEQ tumbles amid new Elan woes
The ISEQ fell 50.78 points in trading this morning to 6,225,17 as Elan was plunged into more trouble with further bad news from the United States.
Elan shares plummeted 50c to €5.07 as the ISEQ opened this morning, after news of a second confirmed death of a patient being treated on a combination including the company's multiple sclerosis drug Tysabri.





